IN MEMORIUM Ludwine M. Messiaen (February 24, 2024)


It is with deep sorrow that the College for Genetics and Rare Diseases announces the passing of Professor Ludwine M. Messiaen (February 24, 2024).

 

She was one of the pioneers of molecular genetic testing in Belgium. She earned her PhD from Ghent University in January 1990, specializing in Biological and Biomedical Sciences.  In 2003 she moved to the USA and was appointed as Laboratory Director of the Medical Genomics lab at the University of Alabama in Birmingham. She was considered as the world expert in molecular testing of neurofibromatosis type 1 and related diseases.

 

She helped thousands of patients by detecting the underlying genetic cause of their disease. Moreover, professor Messiaen's unwavering dedication, enthusiasm, and groundbreaking research have transformed our comprehension of NF, leading to advancements in treatment and care. In 2018, she received the Children's Tumor Foundation's Friedrich von Recklinghausen Award, recognizing her immense contributions in the field of neurofibromatosis. 

 

We will remember her as an inspiring and dedicated geneticist, and as a colorful, creative and warm person. 

 

We extend our heartfelt condolences to her family, friends, and colleagues during this difficult time.

IN MEMORIUM Ludwine M. Messiaen (February 24, 2024)
La discrimination génétique? Pas acceptable.

La discrimination génétique? Pas acceptable.

La société européenne de génétique humaine met en garde contre l'utilisation abusive…

En savoir plus
Un «no deal Brexit» pourrait avoir un impact néfaste sur 4 millions de personnes atteintes d'une maladie rare

Un «no deal Brexit» pourrait avoir un impact néfaste sur 4 millions de personnes atteintes d'une maladie rare

Un groupe d'experts du Royaume-Uni, coordonné par Dr. Marc Tischowitz de l'Université…

En savoir plus
EN MÉMOIRE Gertjan B. van Ommen – 28 septembre 1947 – 7 novembre 2020

EN MÉMOIRE Gertjan B. van Ommen – 28 septembre 1947 – 7 novembre 2020

Le Collège de Génétique et Maladies Rares rapporte avec grand regret le décès de son…

En savoir plus
COVID-19: liste de priorités en génétique clinique

COVID-19: liste de priorités en génétique clinique

En concertation avec les autorités fédérales et en accord avec les associations professionnelles…

En savoir plus
Top